Literature DB >> 12236277

Cluster randomised controlled trial of an educational outreach visit to improve influenza and pneumococcal immunisation rates in primary care.

A Niroshan Siriwardena1, Aly Rashid, Mark R D Johnson, Michael E Dewey.   

Abstract

BACKGROUND: Improvement in the delivery of influenza and pneumococcal vaccinations to high-risk groups is an important aspect of preventive care for primary healthcare teams. AIM: To investigate the effect of an educational outreach visit to primary healthcare teams on influenza and pneumococcal vaccination uptake in high-risk patients.
DESIGN: Cluster randomised controlled trial.
SETTING: Thirty general practices in the Trent region, UK.
METHODS: Fifteen practices were randomised to intervention and 15 to the control group after stratifying for baseline vaccination rate. All intervention practices were offered and received an educational outreach visit to primary healthcare teams, in addition to audit and feedback directed at improving influenza and pneumococcal vaccination rates in high-risk groups. Control practices received audit and feedback alone. All practices measured influenza and pneumococcal vaccination rates in high-risk groups. Primary outcomes were improvements in vaccination rates in patients aged 65 years and over, and patients with coronary heart disease (CHD), diabetes and a history of splenectomy.
RESULTS: Improvements in pneumococcal vaccination rates in the intervention practices were significantly greater compared with controls in patients with CHD, 14.8% versus 6.5% (odds ratio [OR] = 1.23, 95% confidence interval [CI] = 1.13 to 1.34) and diabetes, 15.5% versus 6.8% (OR = 1.18, 95% CI = 1.08 to 1.29) but not splenectomy, 6.5% versus 4.7% (OR = 0.96, 95% CI = 0.65 to 1.42). Improvements for influenza vaccination were also usually greater in intervention practices but did not reach statistical significance. The increases for influenza vaccination in intervention versus control practices were for CHD, 18.1% versus 13.1% (OR = 1.06, 95% CI = 0.99 to 1.12); diabetes, 15.5% versus 12.0% (OR = 1.07, 95% CI = 0.99 to 1.16), splenectomy 16.1% versus 2.9% (OR = 1.22, 95% CI = 0.78 to 1.93); and those over 65 years 20.7% versus 25.4% (OR = 0.99, 95% CI = 0.96 to 1.02).
CONCLUSION: Practices where primary care teams received an educational outreach visit demonstrated a significantly greater improvement in uptake in high-risk groups for pneumococcal but not influenza vaccine.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12236277      PMCID: PMC1314414     

Source DB:  PubMed          Journal:  Br J Gen Pract        ISSN: 0960-1643            Impact factor:   5.386


  41 in total

1.  Family doctor advice is the main determinant of pneumococcal vaccine uptake.

Authors:  M H Kyaw; J S Nguyen-Van-Tam; J C Pearson
Journal:  J Epidemiol Community Health       Date:  1999-09       Impact factor: 3.710

Review 2.  Prevention and early treatment of influenza in healthy adults.

Authors:  V Demicheli; T Jefferson; D Rivetti; J Deeks
Journal:  Vaccine       Date:  2000-01-06       Impact factor: 3.641

3.  Cost-effectiveness of strategies to market and train primary health care physicians in brief intervention techniques for hazardous alcohol use.

Authors:  M K Gomel; S E Wutzke; D M Hardcastle; H Lapsley; R B Reznik
Journal:  Soc Sci Med       Date:  1998-07       Impact factor: 4.634

4.  Prevalence and clinical characteristics of left ventricular dysfunction among elderly patients in general practice setting: cross sectional survey.

Authors:  S Morgan; H Smith; I Simpson; G S Liddiard; H Raphael; R M Pickering; D Mant
Journal:  BMJ       Date:  1999-02-06

5.  Clinical effectiveness of pneumococcal vaccine. Meta-analysis.

Authors:  B G Hutchison; A D Oxman; H S Shannon; S Lloyd; C A Altmayer; K Thomas
Journal:  Can Fam Physician       Date:  1999-10       Impact factor: 3.275

Review 6.  Clinical effectiveness, policies, and practices for influenza and pneumococcal vaccines.

Authors:  J S Nguyen-Van-Tam; K R Neal
Journal:  Semin Respir Infect       Date:  1999-06

7.  Effectiveness of influenza vaccination policy at targeting patients at high risk of complications during winter 1994-5: cross sectional survey.

Authors:  J Watkins
Journal:  BMJ       Date:  1997-10-25

8.  Randomised controlled trial of educational package on management of menorrhagia in primary care: the Anglia menorrhagia education study.

Authors:  G R Fender; A Prentice; T Gorst; R M Nixon; S W Duffy; N E Day; S K Smith
Journal:  BMJ       Date:  1999-05-08

9.  Incremental effectiveness of pneumococcal vaccine on simultaneously administered influenza vaccine in preventing pneumonia and pneumococcal pneumonia among persons aged 65 years or older.

Authors:  P O Honkanen; T Keistinen; L Miettinen; E Herva; U Sankilampi; E Läärä; M Leinonen; S L Kivelä; P H Mäkelä
Journal:  Vaccine       Date:  1999-06-04       Impact factor: 3.641

10.  Performance-based physician reimbursement and influenza immunization rates in the elderly. The Primary-Care Physicians of Monroe County.

Authors:  R W Kouides; N M Bennett; B Lewis; J D Cappuccio; W H Barker; F M LaForce
Journal:  Am J Prev Med       Date:  1998-02       Impact factor: 5.043

View more
  18 in total

1.  Managing alleged performance problems--are we ready?

Authors:  Tim Wilson; David Haslam
Journal:  Br J Gen Pract       Date:  2002-09       Impact factor: 5.386

Review 2.  Does telling people what they have been doing change what they do? A systematic review of the effects of audit and feedback.

Authors:  Gro Jamtvedt; Jane M Young; Doris T Kristoffersen; Mary Ann O'Brien; Andrew D Oxman
Journal:  Qual Saf Health Care       Date:  2006-12

3.  Uptake of pneumococcal polysaccharide vaccine in at-risk populations in England and Wales 1999-2005.

Authors:  R G Pebody; J Hippisley-Cox; S Harcourt; M Pringle; M Painter; G Smith
Journal:  Epidemiol Infect       Date:  2007-04-20       Impact factor: 2.451

4.  Evolution of households' responses to the groundwater arsenic crisis in Bangladesh: information on environmental health risks can have increasing behavioral impact over time.

Authors:  Soumya Balasubramanya; Alexander Pfaff; Lori Bennear; Alessandro Tarozzi; Kazi Matin Ahmed; Amy Schoenfeld; Alexander van Geen
Journal:  Environ Dev Econ       Date:  2014-10

Review 5.  Interventions to increase influenza vaccination rates of those 60 years and older in the community.

Authors:  Roger E Thomas; Diane L Lorenzetti
Journal:  Cochrane Database Syst Rev       Date:  2014-07-07

Review 6.  Educational outreach visits: effects on professional practice and health care outcomes.

Authors:  M A O'Brien; S Rogers; G Jamtvedt; A D Oxman; J Odgaard-Jensen; D T Kristoffersen; L Forsetlund; D Bainbridge; N Freemantle; D A Davis; R B Haynes; E L Harvey
Journal:  Cochrane Database Syst Rev       Date:  2007-10-17

Review 7.  Interventions to increase influenza vaccination rates of those 60 years and older in the community.

Authors:  Roger E Thomas; Diane L Lorenzetti
Journal:  Cochrane Database Syst Rev       Date:  2018-05-30

8.  Strategies to increase influenza vaccination rates: outcomes of a nationwide cross-sectional survey of UK general practice.

Authors:  Laura J Dexter; M Dawn Teare; Matthew Dexter; A Niroshan Siriwardena; Robert C Read
Journal:  BMJ Open       Date:  2012-05-11       Impact factor: 2.692

9.  Effectiveness and cost-effectiveness of an educational intervention for practice teams to deliver problem focused therapy for insomnia: rationale and design of a pilot cluster randomised trial.

Authors:  A Niroshan Siriwardena; Tanefa Apekey; Michelle Tilling; Andrew Harrison; Jane V Dyas; Hugh C Middleton; Roderick Ørner; Tracey Sach; Michael Dewey; Zubair M Qureshi
Journal:  BMC Fam Pract       Date:  2009-01-26       Impact factor: 2.497

10.  Drivers for change in primary care of diabetes following a protected learning time educational event: interview study of practitioners.

Authors:  Aloysius Niroshan Siriwardena; Jo B Middlemass; Kate Ward; Carol Wilkinson
Journal:  BMC Med Educ       Date:  2008-01-19       Impact factor: 2.463

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.